PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.400
https://www.valueinhealthjournal.com/article/S1098-3015(11)01962-0/fulltext
Section Title : Muscular-Skeletal Disorders
Section Order : 370
First Page : A304
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01962-0&doi=10.1016/j.jval.2011.08.400
HEOR Topics :
Tags :
Regions :